Reduction of recurrent ischemia with abciximab during continuous ECG- ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE)

Circulation

Volumn 98, Issue 14, 1998, Pages 1358-1364

  Klootwijk, A Peter J ^b   Meij, Simon ^c   Melkert, Rein ^a   Lenderink, Timo ^a   Simoons, Maarten L ^c  

^a CARDIALYSIS   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

Angina; Electrocardiography; Ischemia; Platelet aggregation inhibitors

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; GLYCERYL TRINITRATE; HEPARIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INDICATION; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0344505855     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.14.1358     Document Type: Article

References (20)

1. Krucoff MW, Croll MA, Pope JE, Granger CB, O'Connor CM, Sigmon KN, Wagner BL, Ryan JA, Lee KL, Kereiakes DJ. Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study: performance of a noninvasive method for real-time detection of failed myocardial reperfusion. Circulation. 1993;88:437-446.
2. Dellborg M, Steg PG, Simoons M, Dietz R, Sen S, van den Brand M, Lotze U, Hauck S, van den Wieken R, Himbert D. Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. Eur Heart J. 1995;16:21-29.
3. Klootwijk P, Langer A, Meij S, Green C, Veldkamp RF, Ross AM, Armstrong PW, Simoons ML, for the GUSTO-I ECG-ischaemia monitoring substudy. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST-segment monitoring in the GUSTO-I trial. Eur Heart J. 1996;17:689-698.
4. Klootwijk P, Meij S, von Es GA, Muller EJ, Umans VA, Lenderink T, Simoons ML. Comparison of usefulness of computer assisted continuous 48-hours 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina. Eur Heart J. 1997;18:931-940.
5. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
6. Falk E. Unstable angina pectoris with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699-705.
7. Simoons ML, de Boer MJ, van den Brand MJBM, van Miltenburg AJM, Hoorntje JCA, Heyndrickx GR, van der Wieken LR, de Bono D, Rutsch W, Schaible TF, Weisman HF, Klootwijk P, Nijssen K, Stibbe J, de Feyter PJ, and the European Cooperative Study Group. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. Circulation. 1994;89:596-603.
8. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med. 1994; 330:956-961.
9. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, on behalf of the EPIC Investigators. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 1994;343:881-886.
10. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 1997;349:1429-1435.
11. Braunwald E. Unstable angina: a classification. Circulation. 1989;80: 410-414.
12. van Miltenburg AJM, Simoons ML, Veerhoek RJ, Bossuyt PMM. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol. 1995;25:1286-1292.
13. Dower GE, Machado HB, Osborne JA. On deriving the electrocardiogram from vectorcardiographic leads. Clin Cardiol. 1980;3:87-95.
14. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischaemia as a marker of early unfavourable outcomes in patients with unstable angina. N Engl J Med. 1986;314:1214-1219.
15. Romeo F, Rosano GM, Martuscelli E, Valente A, Reale A. Unstable angina: role of silent ischaemia and total ischaemic time (silent plus painful ischaemia), a 6-year follow-up. J Am Coll Cardiol. 1992;19: 1173-1179.
16. Nademanee K, Intarachot V, Josephson MA, Reiders D, Mody Vaghaiwalla F, Sigh BN. Prognostic significance of silent myocardial ischaemia in patients with unstable angina. J Am Coll Cardiol. 1987; 10:1-9.
17. Langer A, Freeman MR, Armstrong PW. ST-segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol. 1989;13:1495-1502.
18. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease: The FRISC study group. Circulation. 1996;93: 1651-1657.
19. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE, Califf RM, Topol EJ, for the GUSTO -IIa Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333-1341.
20. Hamm CW, Heeschen C, Goldmann BU, Barnathan E, Simoons ML, for the CAPTURE Investigators. Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina. J Am Coll Cardiol. 1998;31:185A. Abstract.